公开(公告)号：US20220071257A1

公开(公告)日：2022-03-10

申请号：US17527919

申请日：2021-11-16

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A23L33/105 ,  A23L33/00 ,  A23L33/10 ,  A23L33/18 ,  A23L33/175 ,  A23L33/16 ,  A23L33/15 ,  A61K31/198 ,  A61K31/525

摘要： Methods for treatment of chronic liver disease and reducing liver fibrosis are provided. These treatments may be achieved using a medical food composition. The medical food is configured specifically for those having chronic liver disease to provide for specific nutritional requirements caused by the chronic liver disease. Testing of the treated patient allows for tracking of progress and to determine if the liver fibrosis is reduced.

公开(公告)号：US11252984B2

公开(公告)日：2022-02-22

申请号：US15681529

申请日：2017-08-21

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A23L33/105 ,  A23L33/00 ,  A23L33/10 ,  A23L33/18 ,  A23L33/175 ,  A23L33/16 ,  A23L33/15 ,  A61K31/198 ,  A61K31/525

摘要： Methods for treatment of chronic liver disease and reversing liver fibrosis are provided. These treatments may be achieved using a medical food composition. The medical food is configured specifically for those having chronic liver disease to provide for specific nutritional requirements caused by the chronic liver disease. Testing of the treated patient allows for tracking of progress and to determine if the liver fibrosis is reversed.

公开(公告)号：US20160302451A1

公开(公告)日：2016-10-20

申请号：US14688400

申请日：2015-04-16

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A23L1/29

CPC分类号： A23L33/105 ,  A23L33/00 ,  A23L33/10 ,  A23L33/15 ,  A23L33/16 ,  A23L33/175 ,  A23L33/18 ,  A23V2002/00 ,  A61K31/198 ,  A61K31/525 ,  A23V2200/32 ,  A23V2250/0606 ,  A23V2250/0612 ,  A23V2250/0616 ,  A23V2250/161 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/21166 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/708 ,  A23V2250/712

摘要： A medical food is provided. The medical food is configured specifically for those having chronic liver disease to provide for specific nutritional requirements caused by the chronic liver disease. In some cases, the medical food contemplated herein may achieve reversal of liver fibrosis.

摘要翻译： 提供医疗食品。 医疗食品被配置为具有慢性肝病的那些，以提供由慢性肝病引起的特定营养需求。 在某些情况下，本文考虑的医疗食品可能会导致肝纤维化的逆转。

公开(公告)号：US07294351B2

公开(公告)日：2007-11-13

申请号：US11287279

申请日：2005-11-28

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A61K35/64

CPC分类号： A61K31/22 ,  A61K31/353 ,  A61K31/7048

摘要： A composition containing fractioned propolis wax isolated without the use of solvents. The composition contains about 24-50 mg/g of total polyphenols, about 11-18% resins, about 77-87% wax, about 2.4-5.0% polyphenols and about 0-5% other materials.

摘要翻译： 含有分离的蜂胶蜡的组合物，不使用溶剂分离。 该组合物含有约24-50mg / g的总多酚，约11-18％的树脂，约77-87％的蜡，约2.4-5.0％的多酚和约0-5％的其它材料。

公开(公告)号：US20070122426A1

公开(公告)日：2007-05-31

申请号：US11287279

申请日：2005-11-28

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A61K36/185 ,  A61K31/7048 ,  A61K31/353 ,  A61K31/22

CPC分类号： A61K31/22 ,  A61K31/353 ,  A61K31/7048

摘要： A composition containing fractioned propolis wax isolated without the use of solvents. The composition contains about 24-50 mg/g of total polyphenols, about 11-18% resins, about 77-87% wax, about 2.4-5.0% polyphenols and about 0-5% other materials.

公开(公告)号：US20070119475A1

公开(公告)日：2007-05-31

申请号：US11287468

申请日：2005-11-28

申请人： Michael Hudnall ,  Frank Artiss

发明人： Michael Hudnall ,  Frank Artiss

IPC分类号： A61C15/00

CPC分类号： A61C15/041

摘要： Dental floss coated with a composition containing fractioned propolis wax isolated without the use of solvents. The dental floss coating composition contains about 24-50 mg/g of total polyphenols, about 11-18% resins, about 77-87% wax, about 2.4-5.0% polyphenols and about 0-5% other materials.

摘要翻译： 涂有含有分离的蜂胶蜡的组合物的牙线，其不使用溶剂分离。 牙线涂料组合物含有约24-50mg / g的总多酚，约11-18％的树脂，约77-87％的蜡，约2.4-5.0％的多酚和约0-5％的其它材料。

公开(公告)号：US20170347696A1

公开(公告)日：2017-12-07

申请号：US15681529

申请日：2017-08-21

申请人： Michael Hudnall

发明人： Michael Hudnall

IPC分类号： A23L33/105 ,  A61K31/198 ,  A23L33/18 ,  A23L33/00 ,  A23L33/16 ,  A23L33/175 ,  A61K31/525 ,  A23L33/15

CPC分类号： A23L33/105 ,  A23L33/00 ,  A23L33/10 ,  A23L33/15 ,  A23L33/16 ,  A23L33/175 ,  A23L33/18 ,  A23V2002/00 ,  A61K31/198 ,  A61K31/525 ,  A23V2200/32 ,  A23V2250/0606 ,  A23V2250/0612 ,  A23V2250/0616 ,  A23V2250/161 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/21166 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/708 ,  A23V2250/712

摘要： Methods for treatment of chronic liver disease and reversing liver fibrosis are provided. These treatments may be achieved using a medical food composition. The medical food is configured specifically for those having chronic liver disease to provide for specific nutritional requirements caused by the chronic liver disease. Testing of the treated patient allows for tracking of progress and to determine if the liver fibrosis is reversed.